SD Biosensor, Inc. (KRX:137310)
South Korea · Delayed Price · Currency is KRW 6,100.00
-50.00 (-0.81%)
Sep 22, 2026, 1:50 PM KST
SD Biosensor Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 738,760 | 710,581 | 694,574 | 655,677 | 2,932,001 | 2,929,961 |
Revenue Growth | 5.15% | 2.31% | 5.93% | -77.64% | 0.07% | 73.77% |
Gross Profit Gross Profit Growth | 341,000 | 321,449 | 336,971 | 122,449 | 1,390,110 | 1,593,176 |
Operating Income Operating Income Growth | -65,800 | -82,853 | -54,471 | -248,085 | 1,146,624 | 1,387,733 |
Net Income Net Income Growth | -729,491 | -512,106 | -98,411 | -467,712 | 911,362 | 1,088,471 |
Earnings Per Share EPS Growth | -6098.16 | -4279.19 | -805.00 | -4219.00 | 8996.76 | 11161.00 |
EPS Growth | - | - | - | - | -19.39% | 69.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 449,515 | 774,175 | 467,750 | 557,717 | 2,069,971 | 1,895,499 |
Total Debt Total Debt Growth | 289,120 | 673,040 | 610,862 | 608,476 | 30,694 | 195,668 |
Net Cash (Debt) Net Cash Growth | 160,395 | 101,135 | -143,112 | -50,759 | 2,039,277 | 1,699,830 |
Net Cash Growth | -1.93% | - | - | - | 19.97% | 306.25% |
Net Cash Per Share Net Cash Per Share Growth | 1340.82 | 845.09 | -1170.66 | -457.86 | 20131.28 | 17430.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 56,743 | 357,516 | 156,527 | -242,319 | 889,008 | 1,234,945 |
Capital Expenditures CapEx Growth | -45,614 | -57,086 | -78,783 | -142,566 | -301,999 | -190,053 |
Free Cash Flow Free Cash Flow Growth | 11,129 | 300,431 | 77,744 | -384,884 | 587,008 | 1,044,892 |
Free Cash Flow Growth | -96.77% | 286.44% | - | - | -43.82% | 137.22% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.16% | 45.24% | 48.52% | 18.68% | 47.41% | 54.37% |
Operating Margin | -8.91% | -11.66% | -7.84% | -37.84% | 39.11% | 47.36% |
Pretax Margin | -107.57% | -129.21% | -31.56% | -66.89% | 42.36% | 49.98% |
Profit Margin | -98.75% | -72.07% | -14.17% | -71.33% | 31.08% | 37.15% |
FCF Margin | 1.51% | 42.28% | 11.19% | -58.70% | 20.02% | 35.66% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 3.37 | 5.27 |
Forward PE | - | 13.43 | 13.43 | 13.43 | 4.73 | 5.53 |
P/FCF Ratio | 66.10 | 3.54 | 16.18 | - | 5.24 | 5.49 |
PS Ratio | 1.00 | 1.50 | 1.81 | 2.13 | 1.05 | 1.96 |